A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis.
Expert Rev Neurother. 2022 Jun;22(6):499-511. doi: 10.1080/14737175.2022.2075263. Epub 2022 Jun 1.
Expert Rev Neurother. 2022.
PMID: 35582858